The Structure of Clinical Trials and Experimental Therapeutics
The Structure of Clinical Trials and Experimental Therapeutics course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Oncology Department and the Department for Continuing Education’s CPD Centre, the week will be led by Prof Rachel Kerr and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
The module can be taken as a stand-alone short course. It includes group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers.
The Structure of Clinical Trials and Experimental Therapeutics course will provide students with the opportunity to learn more about and discuss the following topics:
- The history of drug discovery
- Modern methods of drug discovery
- Preclinical drug development
- First in human studies; proof of concept
- Early Phase I studies
- Phase II/III studies
- Translational research in clinical trials
- Regulatory authorities (CHM, NICE, EMEA, FDA)
What do students say about the course?
"I liked that it presented an overview of all aspects of clinical development."
Associate Principal Scientist, Clinical Research, New Jersey, USA
“Good narrative from bench to bedside for a drug/treatment. Good networking opportunity and interesting to hear view points from attendees from different backgrounds."
Vaccine Programme Coordinator, Oxford, UK
This course can be taken:
as a 5 day short course (for credit or not for credit)
as part of the MSc in Experimental Therapeutics
as part of the Postgraduate Diploma in Health Research
as part of the Postgraduate Certificate in Health Research
This course will be held at the Department for Continuing Education, Rewley House, Oxford.
Short course participants who do not wish to undertake the assessed work required for academic credit but who do satisfy the course attendance requirements will receive a certificate of attendance. The pdf sample above is an illustration only, and the wording will reflect the course and dates attended.
Those successfully completing the course for credit can request a CATS point transcript.
Accommodation is available at the Rewley House Residential Centre, within the Department for Continuing Education, in central Oxford. The comfortable, en-suite, study-bedrooms have been rated as 4-Star Campus accommodation under the Quality In Tourism scheme, and come with tea- and coffee-making facilities, free Wi-Fi access and Freeview TV. Guests can take advantage of the excellent dining facilities and common room bar, where they may relax and network with others on the programme.
This course uses the Department’s online assignment submission system and online courseware. In order to participate in the course, and to prepare and submit your course assignments you will need access to the Internet and a computer meeting our recommended minimum computer specification. Students of this course may use the student computing facilities provided in Departmental buildings.
Stand-alone students: £1950.00
Students on the MSc in Experimental Therapeutics: £1740.00
Details of funding opportunities including grants, bursaries and scholarships are available on our sources of funding page.
The course fee includes:
- Course materials
- Refreshments and a three course lunch on each day of the course
- Access to the following University of Oxford libraries and services:
- Radcliffe Science Library
- Rewley House Continuing Education Library
- Bodleian Libraries e-Resources
- Access to facilities from the Department of Continuing Education, including:
- The Graduate School
- WebLearn virtual learning environment
- Wi-fi access through Oxford Wireless LAN (OWL).
Prof Rachel Kerr
Rachel gained a BSc (Physiology) followed by an MBChB with Honours from University of Birmingham in 1994. After general medical postgraduate training (MRCP) she undertook research into cancer vaccines, leading to the award of her PhD in 2002.
Rachel is Associate Professor of Gastrointestinal Oncology in the Department of Oncology at the University of Oxford and Consultant Medical Oncologist at Oxford University Hospitals NHS Trust within the colorectal cancer multidisciplinary team. She has been the recipient of multiple personal fellowships from the MRC, DH and HEFCE and has authored over 100 papers in the field of colorectal cancer. Rachel is also Clinical Director of Phase 3 Trials at the Oncology Clinical Trials Office (OCTO) based within the University and has extensive experiencing setting up, managing and writing up clinical trials in this area. Rachel has been CI / Co-CI on trials that have recruited almost 15,000 patients over the last 15 years.
The course has been designed to:
- introduce the most commonly used and most important analytical, quantitative and practical methods used in clinical trials and experimental therapeutics
- enable students to understand the principles that underpin clinical trials and research and to enable them to translate that understanding into good clinical practice
- enhance the quality of translational medicine and clinical trial management at the institutions to which students belong
- allow the student to competently analyse and critically assess clinical trial publications.
The course will be taught by a range of scientists leading these areas of research, and there will be significant time programmed to discuss the scientific and sometimes ethical issues raised by this area of medical research. It will include group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers.
A virtual learning environment (VLE) and access to some of the University of Oxford’s online resources will provide support for those taking the course for credit.
Assessment will be based on submission of a set written assignment, not exceeding 4,000 words. The assessment is only undertaken by those taking the course for academic credit.
Those wishing to may apply to take the course with accreditation. The University of Oxford Department for Continuing Education offers Credit Accumulation and Transfer Scheme (CATS) points for the course. Participants attending at least 75% of the taught course and successfully completing assessed assignments are eligible to earn credit equivalent to 20 CATS-equivalent points which may be counted towards a postgraduate qualification.
Application deadline: two weeks before the commencement of the course.
We strongly recommend that you download and save files before completing to ensure that all your changes are saved.
This course requires you to complete the application form and the additional information form below, and submit them alongside a copy of your CV. If you are applying to take this course for academic credit you will also need to complete section two of the reference form and forward it to your referee for completion. Please note that if you are not applying to take the course for academic credit then you do not need to submit a reference.
Please ensure you read the guidance notes before completing the application form, as any errors resulting from failure to do so may delay your application.
- Short Course Application Form and Guidance Notes
- Additional Information Form
- Reference Form
- Terms and Conditions
Terms and conditions
For applicants and students on this course
Sources of funding
Find information on the different ways in which we may be able to help to support you financially whilst you are studying with us.
Level and demands
The course will appeal to health professionals from a wide range of backgrounds, including qualified doctors, especially specialist registrars in clinical pharmacology or in training for other medical sub-specialities; clinical research fellows; pharmacists; nurses; graduates working in the pharmaceutical industry or in academic clinical trials.
To apply for this short course you should:
- be a graduate or have successfully completed a professional training course
- have experience in a health-related field
- demonstrate a suitable level of English (if this is not your first language).